Arrowhead Picks Up Drug-Delivery Technology through Alvos Acquisition
April 12, 2012
Arrowhead Picks Up Drug-Delivery Technology through Alvos Acquisition
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Arrowhead Chief Sees Little Cost Increase Associated with Newly Acquired Peptide Tech
April 19, 2012 / Gene Silencing News - RXi Closes Acquisition of Apthera
April 14, 2011 / Gene Silencing News - Arrowhead Receives Notice of Allowance on Patent Application Covering Delivery Tech
May 9, 2013 / Gene Silencing News - Arrowhead to Raise $36M in Private Stock Offering
May 2, 2013 / Gene Silencing News - With Thermo Fisher Acquiring Life Tech, RNAi Reagent Space Consolidates Further
April 18, 2013 / Gene Silencing News